Description
Denosumab Solution for Injection, marketed under the brand name Xgeva, is a medication used to treat certain conditions related to bone health. It is a monoclonal antibody that targets and inhibits RANKL (Receptor Activator of Nuclear Factor kappa-B Ligand), which plays a crucial role in bone resorption.
Product Description:
- Brand Name: Xgeva
- Generic Name: Denosumab
- Strength: Typically 120 mg per 1.7 mL vial
- Form: Solution for injection
- Administration Route: Subcutaneous (SC)
Indications:
- Bone Metastases from Solid Tumors: Prevention of skeletal-related events in patients with bone metastases from solid tumors.
- Giant Cell Tumor of Bone: Treatment of adults and skeletally mature adolescents with giant cell tumor of bone that is unresectable or where surgical resection is likely to result in severe morbidity.
- Hypercalcemia of Malignancy: Treatment of hypercalcemia of malignancy that is resistant to bisphosphonate therapy.
